- €2.44bn
- €6.02bn
- €442.20m
- 40
- 41
- 85
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 375 | 384 | 392 | 413 | 442 |
Cost of Revenue | |||||
Gross Profit | 247 | 258 | 262 | 280 | 297 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -707 | -62.4 | -942 | 856 | 483 |
Operating Profit | 1,082 | 446 | 1,334 | -443 | -41.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,031 | 391 | 1,279 | -500 | -112 |
Provision for Income Taxes | |||||
Net Income After Taxes | 825 | 313 | 1,023 | -400 | -89 |
Net Income Before Extraordinary Items | |||||
Net Income | 825 | 313 | 1,023 | -400 | -89 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 825 | 313 | 1,023 | -400 | -89 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.34 | 1.27 | 4.14 | -1.62 | -0.36 |
Dividends per Share |